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Abstract
Purpose: Pulmonary tuberculosis (PTB) has clinically significant sequelae, even after recommended treatment comple-
tion. It is important to recognise these sequelae for accurate assessment of severity and treatment planning, if indicated.
Material and methods: We retrospectively analysed contrast-enhanced computed tomography (CT) scans of chest of 
100 patients with previous history of treated pulmonary tuberculosis, excluding those with active pulmonary dis-
ease. CT findings were analysed based on parenchymal, airway, pleural, mediastinal, and vascular sequelae of PTB. 
Results: Parenchymal sequelae included fibrosis with architectural distortion and volume loss (90%), cavities (21%) 
(with aspergillomas noted in 19% of these cases), and tuberculomas (54%). Airway involvement was noted as bron-
chiectasis (77%) and bronchial stenosis (4%) but none with broncholithiasis. Mediastinal sequelae included lymph 
node calcification (74%), fibrosing mediastinitis (1%), and pericardial tuberculosis (2%). Pleural sequelae included 
pleural thickening (22%), with 40.9% of these patients showing calcifications, and one patient with chronic chylous 
pleural effusion. Vascular sequelae included Rasmussen aneurysms (4%), enlarged bronchial arteries (3%), and 
systemic bronchial collaterals in 1% of our patients.
Conclusions: PTB has multiple appalling sequelae, which require due attention and appropriate treatment in sympto-
matic cases. Radiological evaluation forms an integral part in patient assessment and decision making.
Key words: pulmonary tuberculosis sequelae, cavities, tuberculoma, pleural thickening, Rasmussen’s aneurysm.
Correspondence address: 
Dr. Anagha Rajeev Joshi, Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, India, e-mail: anaghajoshi2405@gmail.com
Authors’ contribution: 
A Study design ∙ B Data collection ∙ C Statistical analysis ∙ D Data interpretation ∙ E Manuscript preparation ∙ F Literature search ∙ G Funds collection
Introduction
Pulmonary tuberculosis (PTB) contributes largely to 
the world health burden, not only due to the morbidity 
and mortality associated with active disease but also the 
morbidity associated with its sequelae [1-3]. Incidence 
of pulmonary tuberculosis is on the rise, with associated 
under-nutrition, diabetes, increasing prevalence of immu-
nosuppression associated with AIDS, immunosuppressant 
drugs used with cancer chemotherapy or transplants, etc. 
Variable degree of drug resistance, non-compliance to treat-
ment due to the long duration and various complications 
of the therapy has further added to the predicament [1-4]. 
All this has created a large group of patients who suffer 
from the various sequelae of pulmonary tuberculosis due 
to involvement of the airway, parenchyma, pleura, or pul-
monary vasculature [5,6]. It is imperative to know about 
these sequelae of pulmonary tuberculosis to evaluate the 
severity of involvement and assess their contribution to the 
patients’ symptoms and treatment planning, if indicated. 
We assessed the imaging features of sequelae of pulmonary 
tuberculosis in patients who presented with pulmonary 
symptoms, excluding those with active pulmonary disease.
Material and methods
Subjects
The study was started after approval from the Institution-
al Review Board. We conducted a retrospective observa-
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tional study of contrast-enhanced computed tomography 
(CT) scans of 100 patients referred to our department 
over a period of one year (from January 2018 to Decem-
ber 2018) with previous history of pulmonary tubercu-
losis, treated based on standard recommendations, and 
presenting with pulmonary complaints like dyspnoea, 
cough, expectoration, haemoptysis, etc. Patients below 
18 years of age and those with clinical, radiological, or mi-
crobiological evidence of active pulmonary tuberculosis 
were excluded from the study.
Scanning parameters
CT scans of the chest were performed as a part of routine 
diagnostic work on a 64-slice multiple detector computed 
tomography (MDCT) scanner (Philips Brilliance, Philips 
Medical Systems) after taking informed consent from the 
patients with no change in the hospital protocol. 
Images were acquired in thin collimation depending 
on the phase. Image reconstruction was carried out on 
a Terarecon Aquarius workstation. Axial images were re-
constructed using a slice thickness of 2.5 mm and 2.5 mm 
reconstruction increment, thinner if necessary, and viewed 
at standard soft tissue window settings. The scans were in-
dependently reviewed by two radiologists, and any disa-
greement was resolved by combined review of the scans 
and a consensus was reached. 
Multi-detector computed tomography evaluation
CT findings were analysed based on parenchymal, airway, 
pleural, mediastinal, and vascular sequelae of tuberculo-
sis. Parenchymal sequelae were classified as fibrosis with 
architectural distortion and volume loss, cavities, and tu-
berculomas. Fibrosis was objectively graded in each lung as 
follows: involving less than the volume of a bronchopulmo-
nary segment as 1 point; and involving an entire volume of 
a segment as 2 points. Each lung involvement was graded 
accordingly with maximum points of the right lung being 
20 and left lung being 16. Cavities were studied based on the 
number (single or multiple) and the thickness of the cavity 
wall, wall enhancement, and calcification. Complications 
like aspergillomas or bronchogenic carcinoma were noted.
Airway involvement was studied on the basis of bron-
chiectasis with its types and extent, bronchial stenosis, and 
broncholithiasis. Mediastinal sequelae included lymph 
node calcification, fibrosing mediastinitis, and pericardial 
tuberculosis.
Pleural sequelae include pleural thickening, which was 
evaluated on the basis of pleural thickness, enhancement, and 
calcification. Fibrothorax was characterised by diffuse pleural 
thickening with or without calcification and is frequently as-
sociated with volume loss of the affected hemithorax. 
Vascular sequelae that were studied included Rasmus-
sen aneurysms, enlarged bronchial arteries, and vasculitis 
leading to thrombosis.
Statistical analysis
Data was analysed using Statistical Package for Social 
Sciences (SPSS) version 17.0 for Windows (SPSS, Chicago 
IL, U.S.A). Mean and standard deviation were calculated 
for continuous variables. Proportions and frequency ta-
bles were used to analyse categorical variables.
Results
We retrospectively analysed contrast-enhanced CT scans 
of the chest in 100 patients with previous history of treated 
pulmonary tuberculosis, with a mean age of 50.7 ±1.8 years 
(18-85 years). Of these patients, 48 were males (48%) and 
52 (52%) were females.
CT findings were analysed based on parenchymal, 
airway, pleural, mediastinal, and vascular sequelae of tu-
berculosis. 
Ninety patients (90%) presented with parenchymal fi-
brosis, architectural distortion (Figure 1), and associated 
volume loss; with the commonest pattern of involvement 
being bilateral upper lobes (32/90 [35.56%]). The volume 
of lung involvement was objectively graded, and the mean 
score of parenchymal involvement was 9.3 ±4.4 (range, 
2-20). Bronchogenic carcinoma was not noted in any of 
our patients. 
Cavities were seen in 21 patients (21%), with 10/21 
patients (47.62%) showing a single cavity (Figure 2) and 
11/21 patients (52.38%) showing multiple cavities. All pa-
tients with solitary cavities showed associated parenchymal 
fibrosis (10/10, 100%), while 8/10 (80%) showed tubercu-
lomas with calcification. Also, solitary cavities were more 
commonly seen in upper lobes (9/10, 90%), with only one 
patient showing a solitary healed cavity in the superior seg-
ment of the right lower lobe (1/10, 10%). The average wall 
thickness of the cavities was 2.9 ±0.7 mm (2-4 mm). All 
the cavities showed smooth non-enhancing walls. Solitary 
cavities most commonly showed upper lobe distribution, 
while when the cavities were multiple, other lobes were 
involved, including superior segments of bilateral lower 
lobes and right middle lobe. Aspergillomas were noted in 
4/21 patients with pulmonary cavities (19%) (Figure 3), all 
the aspergillomas being in the upper lobes.
Tuberculomas were noted in 54 patients (54%), being 
bilateral in 41/54 patients (75.92%) and unilateral in 13 pa-
tients (24.07%). 48/54 patients (88.89%) showed calcified tu-
berculomas (Figure 4), while 6/54 patients (11.11%) showed 
only non-calcified tuberculomas. All these six patients, how-
ever, showed other sequelae of healed tuberculosis such as 
fibrosis or bronchiectasis. The pattern of calcification was 
diffuse (44/48 [91.67%]) and central (4/48 [8.33%]). The 
average size of the tuberculoma was 6 mm ±1.6 mm (3-10 
mm). Enhancement of the nodules was assessed, with none 
of the tuberculomas in our patients showing enhancement.
Airway involvement was studied on the basis of bron-
chiectasis with its type and extent, bronchial stenosis, and 
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Figure 1. A) Fibrosis with architectural distortion (red arrow) involving the right upper lobe reaching up to the pleura associated with pleural thickening. 
B) Tuberculoma in right upper lobe with adjacent fibrosis reaching the major fissure and (C) associated emphysema and (D) bronchiectasis
A
C
B
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Figure 2. Thin-walled, well-defined cavity in the right upper lobe with mild 
right-sided volume loss
Figure 3. A) Aspergilloma with air crescent sign in a thin-walled cavity in the left upper lobe, which shows with adjacent fibrosis and associated left-sided 
volume loss. B) The aspergilloma shows change of position to dependent aspect on prone scan
A B
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broncholithiasis. Bronchiectasis was noted in 77 patients 
(77%), with 31/77 (40.26%) showing tubular bronchiectasis, 
8/77 (10.39%) showing varicose bronchiectasis, and 38/77 
(49.35%) showing cystic bronchiectasis (Figures 5 and 6). 
Four patients (4%) showed bronchial stenosis with distal 
collapse with fluid bronchogram, two of them involving the 
entire lung (Figure 7). The collapsed lung showed multiple 
areas of parenchymal calcifications. None of the patients in 
our series showed broncholithiasis.
Mediastinal sequelae included lymph node calcifica-
tion, fibrosing mediastinitis, and pericardial tuberculosis. 
Calcified nodes were noted in 74 patients (74%) primarily 
Figure 4. A-D) Axial plain chest computed tomography image mediastinal window showing multiple calcified nodules in both lungs showing diffuse 
calcification suggesting benign aetiology
A
C
B
D
Figure 5. A) Coronal and (B) axial computed tomography lung window images showing varicose and cystic bronchiectasis in both lungs as a sequela of 
tuberculosis
A B
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in pretracheal, paratracheal, precarinal, subcarinal, and 
hilar regions (Figure 8). Twi patients (2%) showed peri-
cardial calcifications, who presented with constrictive peri-
carditis (Figure 9). One patient in our series presented with 
fibrosing mediastinitis, with severe narrowing of the right 
main pulmonary artery (Figure 10). 
Pleural sequelae included pleural thickening, which 
was evaluated on the basis of pleural thickness, enhance-
ment, and calcification. Pleural thickening was noted in 
22 patients (22%), with the average pleural thickness be-
ing 3.3 ±1.04 mm (range, 2-7 mm) (Figure 11). 15/22 
(68.18%) patients showed no pleural enhancement, while 
7/22 (31.81%) showed mild pleural enhancement. No 
pleural nodularity was noted. 9/22 patients with pleural 
thickening (40.9%) showed interrupted calcifications 
(Figure 12). In our series, two patients (2%) showed con-
tinuous thick sheet-like calcification. One patient in our 
series presented with chronic pleural effusion with fat flu-
Figure 6. Coronal computed tomography lung window images showing 
cystic bronchiectasis with collapse of the entire left lung as a sequela of 
tuberculosis
Figure 7. Axial post-contrast chest computed tomography image mediasti-
nal window showing complete collapse of the left lung (red arrow). The left 
main bronchus shows wall thickening and luminal narrowing (black arrow) 
Figure 8. Plain axial computed tomography mediastinal window image 
showing calcified sub-carinal nodes (white arrow)
Figure 9. A) Plain (B) post-contrast axial computed tomography image showing pericardial calcification
A B
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Figure 10. A 55-year-old male patient previously diagnosed with tuberculosis involving mediastinal nodes, presented with progressive dyspnoea. A) Axial 
and (B) coronal post contrast computed tomography image mediastinal window in a showing an ill-defined soft tissue density mildly homogenously en-
hancing mediastinal lesion along the right pulmonary artery completely encasing the artery and causing luminal obliteration (red arrow). It shows a focus 
of calcification (yellow arrow)
A B
Figure 11. Axial post-contrast chest computed tomography image mediastinal 
window showing enhancing smooth pleural thickening involving the right costal 
pleura (black arrow) 
Figure 12. Axial post-contrast chest computed tomography image medias-
tinal window showing enhancing smooth pleural thickening with continu-
ous sheet-like calcification (black arrow) 
Figure 13. A) Axial (B) coronal post-contrast chest computed tomography image mediastinal window showing left-sided chronic pleural effusion with 
enhancing smooth pleural thickening and calcification. Fat-fluid level is noted in the pleural effusion (HU: -102). Chylous pleural effusion was noted on 
pleural fluid evaluation
A B
id level suggesting chylous pleural effusion (Figure 13), 
which was proven on biochemical evaluation of pleural 
fluid.
Vascular sequelae that were studied included Ras-
mussen aneurysms, enlarged bronchial arteries, vascular 
thrombosis due to vasculitis, and systemic bronchial col-
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Figure 14. A 51-year-old male patient, previously treated for pulmonary tuberculosis, presented to the emergency services with chronic cough with mul-
tiple episodes of streaky haemoptysis followed by one episode of severe haemoptysis. A) Coronal post-contrast computed tomography image mediastinal 
window shows a large cavity in the right upper lobe with collapse of the right lung. A Rasmussen aneurysm (yellow arrow) is noted along the inferior wall 
of the cavity. Air crescent sign is seen in the cavity, which is also visible on (B) coronal lung window image (red arrow). This appearance may be seen in 
aspergilloma or a haematoma in the cavity in the presence of Rasmussen’s aneurysm 
A B
Figure 15. Axial post-contrast chest computed tomography image medi-
astinal window showing left-sided volume loss due to collapse of the left 
lung. There is hypertrophy of the bronchial arteries (black arrow)
laterals. Rasmussen’s aneurysm was noted in four patients 
(4%), with the average size being 5 mm (Figure 14). En-
larged bronchial arteries were noted in three (3%) patients 
(Figure 15). No case of vascular thrombosis due to vascu-
litis was noted in our study. Systemic bronchial collaterals 
were noted in one of the patients in our series, with system-
ic collaterals noted from internal mammary artery, inferior 
phrenic artery, posterior intercostal arteries, and left gastric 
artery (Figure 16).
Discussion
Pulmonary sequelae of tuberculosis may lead to sig-
nificant patient morbidity even after complete recom-
mended therapy. It requires specifically targeted therapy 
based on the spectrum of involvement and its severity, 
with the treatment being mostly symptom targeted. Pres-
entations like severe haemoptysis, fibrothorax, aspergillo-
ma, etc. may require interventions. Our study population 
comprised 100 patients (mean age 50.7 ±1.8 years [18-85 
years]) who had completed treatment for pulmonary tu-
berculosis according to standard recommended protocols, 
excluding those with documented active disease. They 
were symptomatic with pulmonary symptoms like dysp-
noea, chest pain, haemoptysis, etc. for which they were 
referred to our department for CT scan of the thorax. CT 
findings were analysed based on parenchymal, airway, 
pleural, mediastinal, and vascular sequelae of tuberculosis.
Lung parenchymal lesions
Cicatrisation and destruction of the lung
Cicatrisation with atelectasis is seen commonly in healed 
post-primary tuberculosis, which may present as marked 
‘nonspecific pattern’ of fibrosis consisting of parenchymal 
bands with architectural distortion and volume loss. There 
may be associated retraction of the hilum, mediastinal shift, 
pulling up of the diaphragm, and compensatory hyperin-
flation of the normal lung segments [5-7]. Apical pleural 
thickening associated with fibrosis and proliferation of 
extrapleural fat is commonly seen. Combinations of pa-
renchymal and airway involvement may lead to complete 
destruction of a lung or a major part of a lung in the end 
stages of tuberculosis. 
Ninety patients (90%) in our series presented with pa-
renchymal fibrosis, architectural distortion, and associat-
ed volume loss, being the commonest presentation in our 
series. The commonest distribution of abnormalities was 
bilateral upper lobes (32/90 [35.56%]), which is consistent 
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Figure 16. A 45-year-old-male patient previously treated for pulmonary 
tuberculosis, presented to the emergency services with multiple episodes 
of haemoptysis. A) Axial post-contrast computed tomography image me-
diastinal window shows multiple arterial collaterals along the mediastinal 
pleura (red arrow). B) Oblique coronal mediastinal window shows dilated 
left phrenic artery with pleural branches multiple arterial collaterals along 
the mediastinal pleura (yellow arrow). C) Oblique sagittal mediastinal win-
dow shows left gastric artery with pleural branches along the mediastinal 
pleura (black arrow)
A
C
B
with the predilection of upper lobes in post-primary tuber-
culosis (TB). Hatipoglu et al. [8] evaluated the high reso-
lution computer tomography (HRCT) finding in patients 
with pulmonary tuberculosis and assessed 34 patients with 
inactive pulmonary tuberculosis. They found that HRCT 
scans showed fibrotic lesions (n = 34 [100%]), distortion of 
bronchovascular structures (n = 32 [94%]), and bronchiec-
tasis (n = 24 [71%]) in patients with inactive tuberculosis. 
This is consistent with the proportion found in our study.
The volume of lung involvement was objectively grad-
ed, and the mean score of parenchymal involvement was 
9.3 ±4.4 (range, 2-20). This underlines the grave effects 
of pulmonary tuberculosis on lung parenchyma and the 
impact it can have on lung function. 
Cavities
Parenchymal cavities are one of the commonest pres-
entations of active post-primary pulmonary tuberculosis. 
Tuberculous cavities heal by two processes: open and 
closed, depending upon the state of the draining bronchus 
[9]. In the open form of healing the lumen of the draining 
bronchus remains patent, the walls of the cavity become 
free of tubercle bacilli, usually in response to therapy, and 
the cavity wall undergoes fibrosis with subsequent epi-
thelialisation. The cavity becomes thin walled because of 
regression of the pericavitary inflammatory reaction, and 
the fibrous walls contract, leading to a residual saccule 
opening into a bronchus. In the closed type of healing, 
the draining bronchus becomes occluded and the cavi-
ty either undergoes atelectasis and scar formation or the 
cavity becomes inspissated, leading to the appearance of 
pulmonary nodule or tuberculoma [6,10]. 
In our study, cavities were seen in 21 patients (21%), 
with 10/21 patients (47.62%) showing a single cavity and 
11/21 patients (52.38%) showing multiple cavities. Pa-
tients presenting with solitary cavities showed upper lobe 
predominance, associated parenchymal fibrosis, and tu-
berculomas with calcification, which indicated previous 
tuberculous aetiology. Patients presenting with multiple 
parenchymal cavities showed upper lobe involvement in 
all cases, with associated involvement of other lobes. 
The average wall thickness of the cavities in our study 
was 2.9 ±0.7 mm (2-4 mm), with all the cavities showing 
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smooth non-enhancing walls. Thin-walled, healed tuber-
culous cavities may mimic bullae, cysts, or pneumatoce-
les when the bronchial communication is not evident. It 
is difficult to reliably differentiate openly healed cavities 
from active disease and other causes of lung cavitation 
solely based on radiological appearance. However, clinical 
scenario and serial imaging may give a clue as to the di-
agnosis. Also, as in our series, healed tuberculous cavities 
are usually associated with adjacent atelectasis or scarring 
and calcifications.
Aspergilloma
Saprophytic aspergillosis (aspergilloma) is characterised 
by Aspergillus infection without tissue invasion. It typical-
ly leads to conglomeration of intertwined fungal hyphae 
admixed with mucus and cellular debris within a pre- 
existent pulmonary cavity or ectatic bronchus [11,12]. 
Approximately 25-55% of patients with aspergilloma 
have a history of chronic cavitary tuberculosis. The prev-
alence of aspergilloma associated with chronic tubercu-
losis has been reported to be 11-15.3%, with haemoptysis 
being the most common clinical complication [6,13-15]. 
CT shows a mobile fungus ball, usually with air inter-
spersed between the masses of mycelia. Also, the rounded 
mass is surrounded by a crescentic air shadow inside the 
lung cavity (air-crescent sign). Calcification of the myce-
lial ball occurs in some cases. The aspergilloma usually 
moves when the patient changes position.
Tuberculomas
Pulmonary tuberculomas can be the manifestation of 
both primary and post-primary TB. A pulmonary tuber-
culoma is a well-circumscribed caseous pulmonary nod-
ule or mass encapsulated by multiple layers of connective 
tissue without surrounding inflammation. The underly-
ing pathogenesis is postulated to be repeated extension 
of bronchopneumonic foci, subsequent necrosis, and 
re-encapsulation of its capsule. Closed healing of cavities 
and a rounded-off, contracted, healing tuberculous lesion 
are suggested as other mechanisms. Tuberculomas can 
be solitary or multiple and range in diameter from 0.5 to 
4.0 cm or greater [6]. Typically, they are smooth or sharply 
defined. Calcification is found in 20-30% of tuberculomas 
and is usually nodular and diffuse [16]. 
In our study, tuberculomas were noted in 54 patients 
(54%), with the majority of the patients showing bilateral 
distribution, being clustered in the upper lobes or superior 
segments of the lower lobes, paralleling the distribution of 
other tuberculous lesions. The average size of the tubercu-
lomas in our study was 6 mm ±1.6 mm, with none of the 
patients showing a tuberculoma more than a centimetre 
in size. Calcification is common in healed tuberculomas 
with the common pattern being diffuse and central. Also, 
patients presenting with only non-calcified tuberculomas 
showed other sequelae of healed tuberculosis like parenchy-
mal fibrosis, bronchiectasis, or calcified mediastinal nodes. 
Airway lesions
Bronchiectasis, tracheobronchial stenosis,  
and broncholithiasis
Bronchiectasis may develop as a result of tuberculous in-
volvement of the bronchial wall and subsequent fibrosis 
or destruction or fibrosis of the lung parenchyma with 
secondary bronchial dilatation. Hatipoglu et al. found that 
bronchiectasis was seen in 71% of patients with inactive 
disease in high-resolution CT [8]. Bronchiectasis located 
in the apical and posterior segments of the right upper 
lobe and apicoposterior segment of the left upper lobe is 
highly suggestive of a tuberculous origin. In our study, 
bronchiectasis was noted in 77% patients, with the ma-
jority showing cystic bronchiectasis, followed by tubular 
bronchiectasis and a few showing varicose bronchiectasis. 
Tracheobronchial stenosis may result from granu-
lomatous changes in the tracheobronchial wall or by ex-
trinsic pressure from enlarged tuberculous peribronchial 
nodes in approximately 2-4% of patients with PTB [6,17]. 
The left main bronchus is most frequently involved in fi-
brotic disease. The CT findings include concentric nar-
rowing of the lumen, uniform thickening of the wall, and 
involvement of a long bronchial segment in the fibrotic 
stage. In our series, 4% patients showed tracheobronchial 
stenosis with distal collapse and fluid bronchogram. One 
of these patients showed involvement of the left main 
bronchus with complete collapse of the left lung, while in 
other patients, lobar bronchi were involved. 
Broncholithiasis is defined as the presence of calcified 
material within the tracheobronchial lumen, commonly seen 
secondarily to a calcified peribronchial tuberculous lymph 
node eroding into the bronchial wall. CT shows a calcified 
lymph node that is either endobronchial or peribronchial 
and is associated with findings of bronchial obstruction, such 
as atelectasis, obstructive pneumonitis, or bronchiectasis. 
Mediastinal lesions
Lymph node calcification
Tuberculous mediastinal lymphadenitis is a frequent man-
ifestation of primary pulmonary tuberculosis. In the active 
stage, tuberculous mediastinal lymph nodes show central 
low attenuation and peripheral rim enhancement in CT. 
With treatment, the nodes first become homogeneous and 
finally disappear or result in a residual mass composed of 
fibrotic tissue and calcifications without low-attenuation 
areas [18]. In our series, 74% of patients showed calcified 
mediastinal nodes, primarily in pretracheal, paratracheal, 
precarinal, subcarinal, and hilar regions. Hatipoglu et al. [8] 
found that 15/34 (44%) patients with inactive pulmonary 
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tuberculosis showed calcified mediastinal and hilar nodes. 
Other common causes of mediastinal nodal calcification 
are sarcoidosis, silicosis, treated lymphoma, and histoplas-
mosis. Clinical history and associated parenchymal chang-
es, however, indicate the appropriate diagnosis.
Pericardial tuberculosis
Tuberculous pericarditis is reported to complicate up to 
1% of cases of tuberculosis. Constrictive pericarditis oc-
curs in about 10% of patients with tuberculous pericar-
ditis. It is characterised by fibrous or calcific constrictive 
thickening of the pericardium, which prevents normal 
diastolic filling of the heart. CT shows pericardial thick-
ening of more than 3 mm with or without pericardial ef-
fusion. In our series, two patients (2%) showed pericardi-
al thickening, with one showing interrupted calcification 
and the other showing sheet like calcification. Pericardial 
calcification is seen most commonly following previous 
trauma/surgery, episode of pericarditis, radiotherapy, in-
fection, and connective tissue disorders [19].
Fibrosing mediastinitis
Fibrosing mediastinitis is postulated to result from 
chronic inflammation associated with profound fibrotic 
changes along the mediastinal structures due to adjacent 
primary granulomatous disease, either via direct infiltra-
tion from granuloma rupture or indirectly via local in-
flammatory processes within regional mediastinal lymph 
nodes. The various causes of fibrosing mediastinitis in-
cludes granulomatous diseases (such as histoplasmosis, 
TB, sarcoidosis), malignancy (such as bronchogenic tu-
mour, lymphoma), trauma, and medication-induced (me-
thysergide), IgG-4-mediated disease [20,21]. 
The development of fibrotic infiltrates/masses has the 
potential to encase and compromise mediastinal structures 
including the airway, oesophagus, and/or major vessels. 
Characteristic findings on CT or magnetic resonance imag-
ing include soft tissue obliteration of normal mediastinal fat 
planes with or without encasement and invasion of adjacent 
structures.
The mediastinal granulomatous lymph nodes coalesce, 
and the development of multiple tuberculous granulomas 
creates both reactive fibrous changes and acute inflammato-
ry changes in the mediastinum. The granulomas evolve into 
fibrosing mediastinitis when reactive changes predominate. 
CT findings include a mediastinal or hilar mass, calcification 
in the mass, tracheobronchial narrowing, pulmonary vessel 
encasement, superior vena cava obstruction, and pulmonary 
infiltrates.
Pleural lesions
Pleural sequelae include pleural thickening, which was 
evaluated on the basis of pleural thickness, enhancement, 
and calcification [22]. Fibrothorax with diffuse pleural 
thickening but without effusion on CT scans suggests in-
activity. Chyliform or pseudochylous pleural effusion is 
a high-lipid non-chylous effusion and is most commonly 
caused by tuberculous empyema. The diseased pleura may 
result in an abnormally slow transfer of cholesterol and 
other lipids, originating from degenerated red and white 
blood cells, out of the pleural space, and lead to accumula-
tion of cholesterol in the pleural fluid. CT shows a fat-flu-
id or fat-calcium level [23].
Pleural thickening was noted in 22 patients (22%), 
with the average pleural thickness being 3.8 mm (range, 
3-9 mm). 8/22 (36.36%) showed pleural enhancement, 
while 9/22 (40.9%) showed interrupted calcifications. 
2/22 patients (9.1%) showed continuous thick calcification 
with ipsilateral volume loss and fibrothorax.
Vascular complications
Rasmussen’s aneurysm is pulmonary artery aneurysm 
which occurs in cavitary tuberculosis, which is caused by 
gradual weakening of adjacent pulmonary arterial wall. 
The granulation tissue replaces the adventitia and media 
of the vessel wall, which is replaced by fibrin, leading to 
thinning and pseudoaneurysm formation. Rasmussen’s 
aneurysm was noted in 4% of our patients, with the av-
erage size being 5 mm. A review of autopsy findings in 
patients with a history of chronic cavitary tuberculosis 
showed a 5% prevalence of Rasmussen aneurysm [24]. 
Haemoptysis is the usual presenting symptom and may 
be life-threatening when it is massive. 
Bronchial arteries may be enlarged in bronchiectasis as-
sociated with tuberculosis or in parenchymal tuberculosis. 
Bronchial arteries in patients with chronic inflammation 
become hypertrophied and lead to development of bron-
chopulmonary and arteriovenous communications. En-
larged bronchial arteries were noted in three (3%) patients. 
Pulmonary arteries and veins in an area of active tu-
berculous infection may demonstrate vasculitis and throm-
bosis. 
Conclusions 
Pulmonary tuberculosis leads to significant morbidity, 
even after completion of the recommended treatment. It 
has multiple appalling parenchymal, airway, pleural, me-
diastinal, and vascular sequelae, which warrant accurate 
diagnosis and timely management in symptomatic cases. 
Radiological evaluation assumes a pivotal role in patient 
assessment and decision making. 
Conflict of interest
The authors report no conflict of interest.
Sneha Satish Deshpande, Anagha Rajeev Joshi, Ankita Shah  
e154 © Pol J Radiol 2020; 85: e144-e154
References
1.  WHO. Global Tuberculosis Report 2018. World Health Organiza-
tion 2018.
2.  Kyu HH, Maddison ER, Henry NJ, et al. The global burden of tu-
berculosis: results from the Global Burden of Disease Study 2015. 
Lancet Infect Dis 2018; 18: 261-284.
3.  Kyu HH, Maddison ER, Henry NJ, et al. Global, regional, and na-
tional burden of tuberculosis, 1990–2016: results from the Global 
Burden of Diseases, Injuries, and Risk Factors 2016 Study. Lancet 
Infect Dis 2018; 18: 1329-1349.
4.  Oxlade O, Murray M. Tuberculosis and poverty: why are the poor 
at greater risk in India? PLoS One 2012; 7: e47533.
5.  Menon B, Nima G, Dogra V, Jha S. Evaluation of the radiological 
sequelae after treatment completion in new cases of pulmonary, 
pleural, and mediastinal tuberculosis. Lung India 2015; 32: 241-245.
6.  Kim HY, Song KS, Goo JM, et al. Thoracic sequelae and complica-
tions of tuberculosis. Radiographics 2001; 21: 839-858.
7.  Van Dyck P, Vanhoenacker FM, Van den Brande P, De Schepper AM. 
Imaging of pulmonary tuberculosis. Eur Radiol 2003; 13: 1771-1785.
8.  Hatipoğlu ON, Osma E, Manisali M, et al. High resolution comput-
ed tomographic findings in pulmonary tuberculosis. Thorax 1996; 
51: 397-402.
9.  Hermel MB, Gershon-Cohen J. Healing mechanisms of tuberculous 
cavities. Radiology 1954; 63: 544-549.
10.  Winer-Muram HT, Rubin SA. Thoracic complications of tuberculo-
sis. J Thorac Imaging 1990; 5: 46-63.
11.  Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary 
aspergillosis. Chest 2002; 121: 1988-1999.
12.  Ortiz-Brizuela E, Ponce-de-León A. Chronic pulmonary asper-
gillosis after pulmonary tuberculosis. Can Med Assoc J 2018; 190: 
E1171-E1171.
13.  Fraser RS, Müller NL, Colman N, Pare PD. Fraser and Paré’s Diag-
nosis of Diseases of the Chest. Vol. 1-4. WB Saunders 1999.
14.  Chatzimichalis A, Massard G, Kessler R, et al. Bronchopulmonary 
aspergilloma: a reappraisal. Ann Thorac Surg 1998; 65: 927-929.
15.  Smith NL, Denning DW. Underlying conditions in chronic pulmo-
nary aspergillosis including simple aspergilloma. Eur Respir J 2011; 
37: 865-872.
16.  Lee KS, Song KS, Lim TH, et al. Adult-onset pulmonary tuberculo-
sis: findings on chest radiographs and CT scans. AJR Am J Roent-
genol 1993; 160: 753-758.
17.  Leung AN. Pulmonary tuberculosis: the essentials. Radiology 1999; 
210: 307-322.
18.  Moon WK, Im JG, Yeon KM, Han MC. Mediastinal tuberculous 
lymphadenitis: CT findings of active and inactive disease. AJR Am 
J Roentgenol 1998; 170: 715-718.
19.  O’Leary SM, Williams PL, Williams MP, et al. Imaging the pericardi-
um: appearances on ECG-gated 64-detector row cardiac computed 
tomography. Br J Radiol 2010; 83: 194-205.
20.  McNeeley MF, Chung JH, Bhalla S, Godwin JD. Imaging of gran-
ulomatous fibrosing mediastinitis. Am J Roentgenol 2012; 199: 
319-327.
21.  Tan R, Martires J, Kamangar N. Tuberculosis-associated fibrosing 
mediastinitis: case report and literature review. J Clin Imaging Sci 
2016; 6: 32.
22.  Müller NL. Imaging of the pleura. Radiology 1993; 186: 297-309.
23.  Song JW, Im JG, Goo JM, et al. Pseudochylous pleural effusion with 
fat-fluid levels: report of six cases. Radiology 2000; 216: 478-480.
24.  Santelli ED, Katz DS, Goldschmidt AM, Thomas HA. Embolization 
of multiple Rasmussen aneurysms as a treatment of hemoptysis. 
Radiology 1994; 193: 396-398.
